Cosmetic Safety Enhancement Act Advances In US House, Still Without Preemption
Executive Summary
Approved by the House Energy and Commerce Health Subcommittee on 11 March, H.R. 5279 still lacks any concrete provisions regarding federal preemption of state and local requirements, though bill author and full committee chair Frank Pallone, D-NJ, remains committed to discussions on the subject. He recognized preemption as “a major issue that I know we have to deal with.”
You may also be interested in...
Two ‘Hot Buttons’ Right Now In Product Testing: Benzene In Sunscreens, PFAS In Cosmetics
Craig Weiss, co-CEO and president of CPT Labs, discusses recent reports driving interest in testing for benzene and PFAS in sunscreens and cosmetic products.
US Senate Wants PFAS Banned From Cosmetics. Should FDA Have A Say?
Per- and polyfluoroalkyl substances are unpopular, sure. But there are thousands of PFAS with dissimilar safety profiles that merit US FDA review ahead of a blanket ban in cosmetic products, industry says.
Cosmetics Industry Should ‘Double Down’ On Self-Regulation While Awaiting Reform Legislation
Covington & Burling attorney Peter Barton Hutt brings historical perspective to the matter of cosmetics reform legislation in US Congress, which stalled out in 2020 after COVID hit the states. He advises companies to continue working to meet and exceed existing regulatory requirements "so that people can’t say that voluntary self-regulation doesn’t work."